Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidances On Qualified Health Claims, New Dietary Ingredients Near – FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA plans to issue guidances clarifying certain First Amendment topics in the near future, according to FDA Center for Food Safety & Applied Nutrition Office of Nutritional Products, Labeling & Dietary Supplements Director Christine Taylor, PhD

You may also be interested in...



Prioritized, Consolidated Health Claims Petitions Requested By FDA’s Levitt

Anticipating an influx of health claims petitions now that less stringent approval standards are in the works, FDA is urging industry to consider limits on the number of submissions

New Dietary Ingredient Safety Standards Should Be FDA Focus – NNFA

FDA should devote its resources to developing safety guidelines for new dietary ingredient submissions, rather than establishing a safety prioritization system for all supplements, NNFA asserts in recent comments to the Institute of Medicine

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel